Tullis — 2015 Investments
1 investments dated 2015 · listed companies and verified rows first · show all
Exagen develops diagnostic and monitoring tests for autoimmune diseases, including tools to distinguish connective tissue disease and assess lupus prognosis and progression.
BiotechDigital HealthHealthtechMedical DevicesVista, US
Thierry Dervieux(Executive Officer)Wendy Swedick(Executive Officer)Fortunato R. Rocca(Executive Officer, Director)Sam Riccitelli(Director)Curt LaBelle(Director)Michael Walsh(Director)
Board seatJames L.L. Tullis· per SEC Form D · $3M raise · filed Jul 2015
Co-investorsCottonwood Technology FundEPIC VENTURESH.I.G. CapitalH.I.G. HealthBridge PartnersSun Mountain CapitalTullis Health Investors
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.